Jubilant Pharma supports nuclear medicine and radiation oncology with a dependable portfolio of radiopharmaceuticals used for routine imaging, staging and treatment evaluation. Their formulations deliver consistent image quality, helping clinicians visualise disease accurately and make well-informed decisions across the care pathway.​ ​ Through Transmedic, Jubilant Pharma ensures cancer centres across Southeast Asia have reliable access to the diagnostic tools that keep oncology workflows running smoothly and confidently.